Sign inGet started

Melian Agustin

Insider CIK 1818064 · FMTX EVP, Research & Development · ALVR Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FMTX Forma Therapeutics Holding D To issuer deriv2022-10-142022-10-14118,000— $00SEC↗
FMTX Forma Therapeutics Holding U Tender2022-10-142022-10-1479,000— $00SEC↗
FMTX Forma Therapeutics Holding A Award deriv2022-07-112022-07-12118,000— $0118,000SEC↗
FMTX Forma Therapeutics Holding A Award2022-07-112022-07-1279,000— $079,000SEC↗
ALVR Allovir, Inc. S Sale2021-10-042021-10-054,711$24.23 $114.1K456,829SEC↗
ALVR Allovir, Inc. S Sale2021-10-042021-10-052,967$25.41 $75.4K453,862SEC↗
ALVR Allovir, Inc. S Sale2021-10-042021-10-05333$26.02 $8.7K453,529SEC↗
ALVR Allovir, Inc. S Sale2021-10-042021-10-0510,678$23.29 $248.7K461,540SEC↗
ALVR Allovir, Inc. S Sale2021-09-282021-09-293,750$24.12 $90.5K472,218SEC↗
ALVR Allovir, Inc. S Sale2021-09-172021-09-202,950$24.01 $70.8K475,968SEC↗
ALVR Allovir, Inc. S Sale2021-09-152021-09-20800$24.03 $19.2K478,918SEC↗
ALVR Allovir, Inc. S Sale2021-07-022021-09-2018,586$19.99 $371.5K479,718SEC↗
ALVR Allovir, Inc. S Sale2021-04-052021-09-2018,212$23.89 $435.1K498,304SEC↗
ALVR Allovir, Inc. S Sale2021-03-222021-03-243,750$25.97 $97.4K516,516SEC↗
ALVR Allovir, Inc. S Sale2021-02-022021-02-0454,849$41.19 $2.26M520,266SEC↗
ALVR Allovir, Inc. A Award deriv2021-01-192021-01-2181,250— $081,250SEC↗
ALVR Allovir, Inc. A Award2021-01-192021-01-2143,750— $0575,115SEC↗
ALVR Allovir, Inc. A Award deriv2020-07-292020-07-31220,700— $0220,700SEC↗